A mathematical model for estimating the likelihood of incapacitation and lethality from the inhalation of toxic gases is presented. The model computes an internal dose, equal to retained toxic gas per body mass, which is used to extrapolate outcomes across species. Account is taken for ventilation changes due to species, activity, and chemical response. The internal dose is correlated with each outcome using a cumulative, log-normal, probability distribution, which allows the estimation of tolerances for any population incidence. No internal interactions of gases are modeled and probabilities are combined independently. The model compares favorably with combined gas and large animal data.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/08958370500516010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Oral Glucose-Lowering Agents vs Insulin for Gestational Diabetes: A Randomized Clinical Trial.
JAMA
January 2025
Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands.
Importance: Metformin and glyburide monotherapy are used as alternatives to insulin in managing gestational diabetes. Whether a sequential strategy of these oral agents results in noninferior perinatal outcomes compared with insulin alone is unknown.
Objective: To test whether a treatment strategy of oral glucose-lowering agents is noninferior to insulin for prevention of large-for-gestational-age infants.
Approaches for extracting daily dosage from free-text prescription signatures in heart failure with reduced ejection fraction: a comparative study.
JAMIA Open
February 2025
Department of Biomedical Informatics, University of Utah, Salt Lake City, UT 84108, United States.
Objective: To compare various methods for extracting daily dosage information from prescription signatures (sigs) and identify the best performers.
Materials And Methods: In this study, 5 daily dosage extraction methods were identified. Parsigs, RxSig, Sig2db, a large language model (LLM), and a bidirectional long short-term memory (BiLSTM) model were selected.
Immune Response to BNT162b2 mRNA COVID-19 Vaccine in a Cohort of Healthcare Workers.
Cureus
December 2024
Internal Medicine, Fundació Assistencial Mútua Terrassa, Terrassa, ESP.
In this 13-month follow-up study, we examined a cohort of vaccinated healthcare workers without prior SARS-CoV-2 infection to assess the humoral and cellular response to the BNT162b2 mRNA COVID-19 vaccine over time. We measured median immunoglobulin G and lymphocyte subpopulation levels after the first and second doses, at five months post-second dose, and before and after the third dose. Our findings evinced a remarkable initial cellular and humoral response to each vaccine dose, although a progressive decline suggests the potential need for long-term booster doses.
View Article and Find Full Text PDFImpact of MLC error on dose distribution in SRS treatment of single-isocenter multiple brain metastases: comparison between DCAT and VMAT techniques.
Rep Pract Oncol Radiother
December 2024
Department of Radiation Oncology, Kagawa University Hospital, Kagawa, Japan.
Background: Dynamic conformal arc therapy (DCAT) and volumetric modulated arc therapy (VMAT) can achieve near equal plan quality in single-isocenter multiple target stereotactic radiosurgery (SRS) for brain metastases. This study aimed to investigate the impact of multi-leaf collimator (MLC) errors during beam delivery on the dose distribution for each technique.
Materials And Methods: A 10-mm diameter delineation of the three targets was employed on the computed tomography images of a head phantom, and the reference plans were created using the DCAT and VMAT.
Reduced- versus full-dose anticoagulants for the extended treatment of cancer-associated venous thromboembolism in Thai patients.
Res Pract Thromb Haemost
January 2025
Department of Internal medicine, Ramathibodi Hospital, Mahidol University, Thailand.
Background: Reduced-dose anticoagulant therapy for extended treatment of cancer-associated venous thromboembolism (VTE) has been used to avoid bleeding. However, it may increase the risk of recurrent VTE.
Objectives: To study the rate of recurrent VTE and bleeding complications in Thai patients with cancer-associated VTE who were treated with full-dos/e or reduced-dose anticoagulants.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!